Evidence map›Paper›PMID 27676096›Full record

ArticleJournal of the American Chemical Society2016

Evaluation of Chromane-Based Bryostatin Analogues Prepared via Hydrogen-Mediated C-C Bond Formation: Potency Does Not Confer Bryostatin-like Biology.

John M Ketcham, Ivan Volchkov, Te-Yu Chen, Peter M Blumberg, Noemi Kedei, Nancy E Lewin, Michael J Krische

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
5.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

John M KetchamDepartment of Chemistry and Biochemistry, University of Texas at Austin , Austin, Texas 78712, United States.
Ivan VolchkovDepartment of Chemistry and Biochemistry, University of Texas at Austin , Austin, Texas 78712, United States.
Te-Yu ChenDepartment of Chemistry and Biochemistry, University of Texas at Austin , Austin, Texas 78712, United States.
Peter M BlumbergLaboratory of Cancer Biology and Genetics, National Cancer Institute, National Institutes of Health , Bethesda, Maryland 20892-4255, United States.
Noemi KedeiLaboratory of Cancer Biology and Genetics, National Cancer Institute, National Institutes of Health , Bethesda, Maryland 20892-4255, United States.
Nancy E LewinLaboratory of Cancer Biology and Genetics, National Cancer Institute, National Institutes of Health , Bethesda, Maryland 20892-4255, United States.
Michael J KrischeDepartment of Chemistry and Biochemistry, University of Texas at Austin , Austin, Texas 78712, United States.
The University of Texas at Austin · USDepartment of Health and Human Services · USNational Cancer Institute · USNational Institutes of Health · US

Funding

Molecular Mechanism of Action of Phorbol EsterZIABC005270 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI BLUMBERG, PETER · 2009 to 2018
$18.4M
Polyketides via Redox-Triggered Alcohol C-H Functionalization.R01GM093905 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI KRISCHE, MICHAEL J · 2011 to 2024
$4.5M
MOLECULAR MECHANISM OF ACTION OF PHORBOL ESTER TUMOR PROMOTERSZ01BC005270 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI BLUMBERG, PETER · 1996 to 2008
$4.3M
CCR NIH HHS HHSN261200800001CIntramural NIH HHS Z01 BC005270NCI NIH HHS HHSN261200800001ENIGMS NIH HHS R01 GM093905
6 · The paper itself

Abstract

The synthesis and biological evaluation of chromane-containing bryostatin analogues WN-2-WN-7 and the previously reported salicylate-based analogue WN-8 are described. Analogues WN-2-WN-7 are prepared through convergent assembly of the chromane-containing fragment B-I with the "binding domain" fragment A-I or its C26-des-methyl congener, fragment A-II. The synthesis of fragment B-I features enantioselective double C-H allylation of 1,3-propanediol to form the C

Indexed as

Antineoplastic AgentsBryostatinsCell Line, TumorCell ProliferationChromansGene Expression Regulation, NeoplasticHumansHydrogenProto-Oncogene Proteins c-aktTumor Necrosis Factor-alphaAntineoplastic AgentsBryostatinsChromansHydrogenProto-Oncogene Proteins c-aktTumor Necrosis Factor-alpha

Identifiers

PMID27676096
PMCPMC5094189
OpenAlexW2421570686

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.